MINISTER OF HEALTH AND FAMILY WELFARE (DR. C.P. THAKUR)
(a) Yes, Sir.
(b) to (d) Certain drugs and formulations withdrawn in some countries at times, continue to be
marketed in other countries because the decision to do so is based on risk assessment process
which is influenced by a number of factors such as the disease pattern in a country, the varying
reactions of certain ethnic groups in a given population to the drug, availability of safer
substitutes as well as the cost factor involved in the treatment of a particular disease etc.
The drugs marketed in the country are examined through an Expert Committee on a continuous basis
to weed out harmful/irrational drugs.
Two Drugs, namely Cisapride and Phenylpropylamine were withdrawn in USA in July, 2000 &
November, 2000 respectively. However, these drugs are also available in countries like Sweden,
Australia etc. with restricted indications. In India also the status of these drugs have
been examined by an Expert Committee and as per the recommendations, the marketing of these
drugs have been allowed for specific indications.
Recently, one cholesterol reducing drug `Cerivastatin` has been withdrawn in USA due to
adverse reports of fatal rhabdimylosis associated with this drug. In India, M/s. Bayer India
Ltd., and M/s Torrent Ahmedabad who were permitted to market Cerivastatin have also withdrawn
it from the market. All State Drug Control Authorities have been directed to ensure that
Cerivastatin tablets are not marketed anywhere in the country.